首页> 外文期刊>The Tohoku Journal of Experimental Medicine >Evaluation of the effectiveness of cervical cancer screening: a case-control study in Miyagi, Japan.
【24h】

Evaluation of the effectiveness of cervical cancer screening: a case-control study in Miyagi, Japan.

机译:宫颈癌筛查有效性的评估:日本宫城县的病例对照研究。

获取原文
获取原文并翻译 | 示例
           

摘要

To estimate the effectiveness of screening for invasive cervical cancer, a case-control study was performed in Miyagi, Japan. A total of 198 cases (129 mass screen-detected and 69 outpatient-detected) of invasive cervical cancer were identified between 1984 and 1990. The results of the Papanicolaou smear of these cases were compared to those of 396 age- (+/- 5 years) and area-matched controls. Compared with women who had no prior screening (cases 51.6%, controls 16.2%), women who were screened had an odds ratio (OR) for invasive cervical cancer of 0.14 (95% confidence interval [CI] 0.088-0.230). The OR for the 175 cases of squamous cell carcinoma was 0.13 (95% CI 0.077-0.215), while the OR for the 23 cases of screened women with adenocarcinoma was 0.40 (95% CI 0.091-1.753). The time intervals following the last negative smear were assessed and we found an OR for a one-year interval and a two-year interval of 0.09 (95% CI 0.055-0.163) and 0.17 (95% CI 0.083-0.335), respectively. In conclusion, screeningfor invasive cervical cancer is not only effective but also the degree of protection is high for one to two years.
机译:为了评估筛查浸润性宫颈癌的有效性,在日本宫城县进行了一项病例对照研究。在1984年至1990年之间,共鉴定了198例浸润性子宫颈癌病例(筛查出129例肿块,门诊发现69例)。将这些病例的巴氏涂片检查结果与396例年龄(+/- 5年)和区域匹配的控件。与没有进行过筛查的女性(病例51.6%,对照组16.2%)相比,接受筛查的女性浸润性宫颈癌的优势比(OR)为0.14(95%置信区间[CI] 0.088-0.230)。 175例鳞状细胞癌的OR为0.13(95%CI 0.077-0.215),而23例经筛查的腺癌女性的OR为0.40(95%CI 0.091-1.753)。评估最后一次阴性涂片后的时间间隔,我们发现一年间隔和两年间隔的OR分别为0.09(95%CI 0.055-0.163)和0.17(95%CI 0.083-0.335)。总而言之,筛查浸润性宫颈癌不仅有效,而且防护程度在一到两年内都很高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号